High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial-Reference-Cited by-同舟云学术

High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial

Published:2017-01 Issue:1 Volume:17 Page:39-49
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Boeree Martin J,Heinrich Norbert,Aarnoutse Rob,Diacon Andreas H,Dawson Rodney,Rehal Sunita,Kibiki Gibson S,Churchyard Gavin,Sanne Ian,Ntinginya Nyanda E,Minja Lilian T,Hunt Robert D,Charalambous Salome,Hanekom Madeleine,Semvua Hadija H,Mpagama Stellah G,Manyama Christina,Mtafya Bariki,Reither Klaus,Wallis Robert S,Venter Amour,Narunsky Kim,Mekota Anka,Henne Sonja,Colbers Angela,van Balen Georgette Plemper,Gillespie Stephen H,Phillips Patrick P J,Hoelscher Michael

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference35 articles.

1. Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946–1986, with relevant subsequent publications;Fox;Int J Tuberc Lung Dis,1999

2. Why do we use 600 mg of rifampicin in tuberculosis treatment?;van Ingen;Clin Infect Dis,2011

3. Optimization of the rifampin dosage to improve the therapeutic efficacy in tuberculosis treatment using a murine model;de Steenwinkel;Am J Respir Crit Care Med,2013

4. High-dose rifampicin kills persisters, shortens treatment duration, and reduces relapse rate in vitro and in vivo;Hu;Front Microbiol,2015

5. Dose-ranging comparison of rifampin and rifapentine in two pathologically distinct murine models of tuberculosis;Rosenthal;Antimicrob Agents Chemother,2012

Cited by 292 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis, and biological evaluation of 1,2,4-triazole derivatives as potent antitubercular agents;Chinese Chemical Letters;2024-03

2. The quest to deliver high-dose rifampicin: can the inhaled approach help?;Expert Opinion on Drug Delivery;2024-01-02

3. The TuberXpert project protocol: Towards a Clinical Decision Support System for therapeutic anti-tuberculosis medical drugs monitoring in Tanzania;2023-12-24

4. Hybrid use of Raman spectroscopy and artificial neural networks to discriminate Mycobacterium bovis BCG and other Mycobacteriales;PLOS ONE;2023-12-11

5. Risk adjustment model for tuberculosis compared to non-tuberculosis mycobacterium or latent tuberculosis infection: Center for Personalized Precision Medicine of Tuberculosis (cPMTb) cohort database;BMC Pulmonary Medicine;2023-11-24